Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin

NCT01907854 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01907854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01907854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
Lead sponsor
Novo Nordisk A/S
Phase
Phase 4
Overall status
Completed
Start date
December 2, 2013
Completion date
June 15, 2015
Enrollment
407 (actual)
Sites
106

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2